is medical and biological technology the general trend? And listen to investors and entrepreneurs how to interpret

Under the trend of mergers and acquisitions, http://www.aliyun.com/zixun/aggregation/13786.html "> Pharmaceutical industry changes constantly, production and sales downlink and strict policies, 2014 of the industry situation is no longer optimistic?" Pharmacy trusteeship and Online Pharmacy, one is the traditional transformation, one is the platform of the growth of the electricity quotient, which can become the future of the pharmaceutical industry more ideal business model? Biotechnology development is breaking through innovation to compensate for medical needs, biological diagnostics, genetically modified food will go?

Wang Tingchun, chairman and general manager of Bo Pharmaceutical Biology, Guangzhou, said at the fourth session of the China Healthcare industry investment and mergers and acquisitions conference sponsored by the Qing Ke group, China has about 6,000 pharmaceutical companies that can really do about 200-300 of new compounds, and a new drug from the discovery of compounds to the final drug market, Requires a very complex and lengthy process. This process requires the support of investment agencies, although the cycle will be very long, but once the research and development success, the return on investment will be very substantial.

Guo Haitao, executive partner of the investment group, who holds a different view, said that in the current China situation, the choice between generics and innovative drugs would be based on generic drugs. General venture capital institutions will not invest in hospitals, investment in hospitals are generally insurance and pension funds, because VC/PE investment for the purpose of profit, and from the global perspective, the hospital's investment mainly in the public good.

The President and CEO of the United States (Origene) is not pointed out that the biological medicine is a burning money industry, but also a very high threshold of the industry, to do drugs to deal with the Drug Administration; opening a hospital requires dealing with the government. However, he is clearly confident in the Chinese market-China's health care as long as the market economy of this road, will certainly be able to make a lot of money, just need to step on the point of time. "Biomedical Care is an industry that can be permanently invested." "What is not said," the industry will do 200 years no problem. ”

Tianjin Tianjin Haida investment in pharmaceutical investment, managing director Chenqiao pointed out that from the whole market background, medical economic operation in a weak period, from the point of view of investment, level and two prices upside down, now the traditional model of the pharmaceutical industry is more and more difficult to do, at present, is focusing on mergers and acquisitions, the traditional pharmaceutical field, Recent mergers and acquisitions have more opportunities than traditional venture opportunities.

Talking about the industry's prospects, Wang Tingchun that new drugs, new devices and health foods are very promising.